ARDOX-X Trademark

Trademark Overview

On Thursday, May 22, 2008, a trademark application was filed for ARDOX-X with the United States Patent and Trademark Office. The USPTO has given the ARDOX-X trademark a serial number of 77481096. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 13, 2012. This trademark is owned by Terra Nova Pharmaceutical N.V.. The ARDOX-X trademark is filed in the Pharmaceutical Products category with the following description:

Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic and veterinary purposes
ardox-x

General Information

Serial Number77481096
Word MarkARDOX-X
Filing DateThursday, May 22, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 13, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements

Goods and ServicesMolecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic and veterinary purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTerra Nova Pharmaceutical N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCuracao
AN
Party NameTerra Nova Pharmaceutical N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCuracao
AN

Trademark Events

Event DateEvent Description
Monday, August 13, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 13, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, January 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2012EXTENSION 5 GRANTED
Tuesday, January 3, 2012EXTENSION 5 FILED
Tuesday, January 3, 2012TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2011EXTENSION 4 GRANTED
Wednesday, July 13, 2011EXTENSION 4 FILED
Wednesday, July 13, 2011TEAS EXTENSION RECEIVED
Tuesday, January 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2011EXTENSION 3 GRANTED
Wednesday, January 5, 2011EXTENSION 3 FILED
Wednesday, January 5, 2011TEAS EXTENSION RECEIVED
Tuesday, August 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2010EXTENSION 2 GRANTED
Wednesday, July 14, 2010EXTENSION 2 FILED
Monday, August 16, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 14, 2010TEAS EXTENSION RECEIVED
Thursday, January 14, 2010EXTENSION 1 GRANTED
Thursday, January 14, 2010EXTENSION 1 FILED
Thursday, January 14, 2010TEAS EXTENSION RECEIVED
Tuesday, July 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 15, 2009ASSIGNED TO EXAMINER
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Tuesday, March 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 17, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 16, 2009ASSIGNED TO LIE
Monday, March 16, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 15, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 15, 2008NON-FINAL ACTION E-MAILED
Monday, September 15, 2008NON-FINAL ACTION WRITTEN
Monday, September 8, 2008ASSIGNED TO EXAMINER
Tuesday, May 27, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

ardox surgical therapeutic veterinary purposes medicinal oxygen complex delivery radical molecular